Paper41301040
The Role of Quantitative Ultrasound in Monitoring Neoadjuvant Chemotherapy in Breast Cancer: A Narrative Review.
Piotrzkowska-Wróblewska H. Cancers (Basel), 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. The Role of Quantitative Ultrasound in Monitoring Neoadjuvant Chemotherapy in Breast Cancer: A Narrative Review. Papers, record 41301040. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301040
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Role of Quantitative Ultrasound in Monitoring Neoadjuvant Chemotherapy in Breast Cancer: A Narrative Review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1/2025 | Polpharma Scientific Foundation | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42512430 | Correction: Piotrzkowska-Wróblewska, H. The Role of Quantitative Ultrasound in Monitoring Neoadjuvant Chemotherapy in Breast Cancer: A Narrative Review. Cancers 2025, 17, 3676. | https://conductscience.org/library/papers/42512430 |
Source PubMed
References111
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40305609 | A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer. | Sci Adv | 2025 | https://conductscience.org/library/papers/40305609 | PubMed |
| 2 | 33878210 | Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer. | Cancer | 2021 | https://conductscience.org/library/papers/33878210 | PubMed |
| 3 | 34954844 | Assessment of breast cancer response to neoadjuvant chemotherapy based on ultrasound backscattering envelope statistics. | Med Phys | 2022 | https://conductscience.org/library/papers/34954844 | PubMed |
| 4 | 30679171 | Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. | Cancer Discov | 2019 | https://conductscience.org/library/papers/30679171 | PubMed |
| 5 | 17112950 | Examination of cancer in mouse models using high-frequency quantitative ultrasound. | Ultrasound Med Biol | 2006 | https://conductscience.org/library/papers/17112950 | PubMed |
| 6 | 31548545 | Breast cancer. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/31548545 | PubMed |
| 7 | 25534283 | Non-invasive evaluation of breast cancer response to chemotherapy using quantitative ultrasonic backscatter parameters. | Med Image Anal | 2015 | https://conductscience.org/library/papers/25534283 | PubMed |
| 8 | 28260181 | Breast cancer in young women: an overview. | Updates Surg | 2017 | https://conductscience.org/library/papers/28260181 | PubMed |
| 9 | 34019819 | Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/34019819 | PubMed |
| 10 | 31325763 | Breast Cancer Treatment Response Monitoring Using Quantitative Ultrasound and Texture Analysis: Comparative Analysis of Analytical Models. | Transl Oncol | 2019 | https://conductscience.org/library/papers/31325763 | PubMed |
| 11 | 26415165 | Unifying Concepts of Statistical and Spectral Quantitative Ultrasound Techniques. | IEEE Trans Med Imaging | 2016 | https://conductscience.org/library/papers/26415165 | PubMed |
| 12 | 19097774 | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19097774 | PubMed |
| 13 | 34499249 | Quantitative ultrasound imaging of soft biological tissues: a primer for radiologists and medical physicists. | Insights Imaging | 2021 | https://conductscience.org/library/papers/34499249 | PubMed |
| 14 | 34298733 | Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298733 | PubMed |
| 15 | 37270368 | Deep Learning Model Based on Dual-Modal Ultrasound and Molecular Data for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer. | Acad Radiol | 2023 | https://conductscience.org/library/papers/37270368 | PubMed |
| 16 | 38724768 | Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study. | Eur Radiol | 2024 | https://conductscience.org/library/papers/38724768 | PubMed |
| 17 | 24939867 | Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture. | Oncotarget | 2014 | https://conductscience.org/library/papers/24939867 | PubMed |
| 18 | 27105515 | Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach. | Oncotarget | 2016 | https://conductscience.org/library/papers/27105515 | PubMed |
| 19 | 21814749 | A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/21814749 | PubMed |
| 20 | 36074908 | Breast cancer: an up-to-date review and future perspectives. | Cancer Commun (Lond) | 2022 | https://conductscience.org/library/papers/36074908 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42512430 | Correction: Piotrzkowska-Wróblewska, H. The Role of Quantitative Ultrasound in Monitoring Neoadjuvant Chemotherapy in Breast Cancer: A Narrative Review. Cancers 2025, 17, 3676. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512430 | PubMed |
| 42253942 | Radiomics: Current Applications and Future Directions. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42253942 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41301040
GET https://conductscience.org/api/papers/v1/41301040/references?page=2